Global Health Ltd.
Research Global Health Ltd. (MEDANTA.NS) on Bullrun: market cap INR 333.22B, P/E 60.0, dividend yield 0.0%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerMEDANTA.NS
- ExchangeNSE
- CountryIndia
- SectorHealthcare
- IndustryMedical Care Facilities
- CurrencyINR
- Market capINR 333.22B
- P/E60.0
- Dividend yield0.0%
- Financial periodQ2 2026
- RevenueINR 13.04B
- Net incomeINR 1.59B
- Gross margin77.4%
Valuation Snapshot
latest market cap is INR 333.22B; P/E is 60.0; dividend yield is 0.0%.
Peer valuation comparison
Latest P/E is 59.96x versus a Healthcare sector median of 21.74x (175.8% above).
Latest dividend yield is 0.04% versus a Healthcare sector median of 2.4% (98.3% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | INR 333.22B | 60.0 | 0.0% | 0.5 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.5 INR, yield 0.0%.
About Global Health Ltd.
Global Health Limited, together with its subsidiaries, provides healthcare services in India. The company offers treatments in the areas of digestive and hepatobiliary sciences, cardiac and cancer care, neurosciences, gastrosciences, orthopaedics, renal care, liver transplant, lung transplant, bone marrow transplant, chest surgery, gynaecology and gynaeoncology, paediatric care, obstetrics, emergency, ENT, head and neck surgery, internal medicine, respiratory and sleep medicine, peripheral vascular and...
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Global Health Ltd.'s market cap?
Global Health Ltd.'s market capitalization is INR 333.22B.
What is Global Health Ltd.'s P/E ratio?
Global Health Ltd.'s price-to-earnings (P/E) ratio is 60.0.
Does Global Health Ltd. pay a dividend?
Global Health Ltd. has a dividend yield of 0.0%.
What does Global Health Ltd. do?
Global Health Limited, together with its subsidiaries, provides healthcare services in India. The company offers treatments in the areas of digestive and hepatobiliary sciences, cardiac and cancer care, neurosciences, gastrosciences, orthopaedics, renal care, liver transplant, lung transplant, bone marrow transplant, chest surgery, gynaecology and gynaeoncology, paediatric care, obstetrics, emergency, ENT, head and neck surgery, internal medicine, respiratory and sleep medicine, peripheral vascular and endovascular sciences, endocrinology and diabetes, rheumatology and immunology, radiology.